HEADER LIGASE 09-OCT-19 6UMB TITLE CRYSTAL STRUCTURE OF TRIM7 B30.2 DOMAIN AT 1.8 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE TRIM7; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: B30.2 DOMAIN; COMPND 5 SYNONYM: GLYCOGENIN-INTERACTING PROTEIN,RING FINGER PROTEIN 90, COMPND 6 TRIPARTITE MOTIF-CONTAINING PROTEIN 7; COMPND 7 EC: 2.3.2.27; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE TRIM7; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: B30.2 DOMAIN; COMPND 13 SYNONYM: GLYCOGENIN-INTERACTING PROTEIN,RING FINGER PROTEIN 90, COMPND 14 TRIPARTITE MOTIF-CONTAINING PROTEIN 7; COMPND 15 EC: 2.3.2.27; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TRIM7, GNIP, RNF90; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: TRIM7, GNIP, RNF90; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS B30.2, E3 UBIQUITIN LIGASE, PRY/SPRY, TRIM7, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR C.J.MUNOZ SOSA,M.E.CARRIZO REVDAT 4 11-OCT-23 6UMB 1 REMARK REVDAT 3 14-JUL-21 6UMB 1 JRNL REVDAT 2 23-JUN-21 6UMB 1 JRNL REVDAT 1 14-APR-21 6UMB 0 JRNL AUTH C.J.MUNOZ SOSA,F.M.ISSOGLIO,M.E.CARRIZO JRNL TITL CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF THE HUMAN TRIM7 JRNL TITL 2 B30.2 DOMAIN PROVIDE INSIGHTS INTO THE MOLECULAR BASIS OF JRNL TITL 3 ITS BINDING TO GLYCOGENIN-1. JRNL REF J.BIOL.CHEM. V. 296 00772 2021 JRNL REFN ESSN 1083-351X JRNL PMID 33989636 JRNL DOI 10.1016/J.JBC.2021.100772 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0257 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 32144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1661 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2299 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 110 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2771 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.90000 REMARK 3 B22 (A**2) : 0.29000 REMARK 3 B33 (A**2) : 1.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.130 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.089 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.918 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2879 ; 0.011 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2625 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3905 ; 1.685 ; 1.650 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6058 ; 1.368 ; 1.572 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 349 ; 8.246 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;28.697 ;19.704 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 441 ;13.914 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;18.608 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 344 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3252 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 688 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6UMB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1000244846. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LNLS REMARK 200 BEAMLINE : W01B-MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.4586 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33860 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.54600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4N7I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM MALONATE PH 6.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.18000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.84500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.72000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.84500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.18000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.72000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 335 REMARK 465 HIS A 336 REMARK 465 MET A 337 REMARK 465 LYS A 338 REMARK 465 SER B 335 REMARK 465 HIS B 336 REMARK 465 MET B 337 REMARK 465 LYS B 338 REMARK 465 GLU B 339 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 340 94.88 60.79 REMARK 500 THR A 382 -51.10 -130.56 REMARK 500 SER A 459 -51.54 -121.34 REMARK 500 THR B 382 -48.70 -132.54 REMARK 500 SER B 454 72.99 -100.76 REMARK 500 SER B 459 -53.59 -122.80 REMARK 500 TYR B 484 147.56 -172.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MLI A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MLI B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME B 602 DBREF 6UMB A 338 511 UNP Q9C029 TRIM7_HUMAN 338 511 DBREF 6UMB B 338 511 UNP Q9C029 TRIM7_HUMAN 338 511 SEQADV 6UMB SER A 335 UNP Q9C029 EXPRESSION TAG SEQADV 6UMB HIS A 336 UNP Q9C029 EXPRESSION TAG SEQADV 6UMB MET A 337 UNP Q9C029 EXPRESSION TAG SEQADV 6UMB SER B 335 UNP Q9C029 EXPRESSION TAG SEQADV 6UMB HIS B 336 UNP Q9C029 EXPRESSION TAG SEQADV 6UMB MET B 337 UNP Q9C029 EXPRESSION TAG SEQRES 1 A 177 SER HIS MET LYS GLU GLU LYS VAL GLU LEU THR LEU ASP SEQRES 2 A 177 PRO ASP THR ALA ASN PRO ARG LEU ILE LEU SER LEU ASP SEQRES 3 A 177 LEU LYS GLY VAL ARG LEU GLY GLU ARG ALA GLN ASP LEU SEQRES 4 A 177 PRO ASN HIS PRO CME ARG PHE ASP THR ASN THR ARG VAL SEQRES 5 A 177 LEU ALA SER CME GLY PHE SER SER GLY ARG HIS HIS TRP SEQRES 6 A 177 GLU VAL GLU VAL GLY SER LYS ASP GLY TRP ALA PHE GLY SEQRES 7 A 177 VAL ALA ARG GLU SER VAL ARG ARG LYS GLY LEU THR PRO SEQRES 8 A 177 PHE THR PRO GLU GLU GLY VAL TRP ALA LEU GLN LEU ASN SEQRES 9 A 177 GLY GLY GLN TYR TRP ALA VAL THR SER PRO GLU ARG SER SEQRES 10 A 177 PRO LEU SER CYS GLY HIS LEU SER ARG VAL ARG VAL ALA SEQRES 11 A 177 LEU ASP LEU GLU VAL GLY ALA VAL SER PHE TYR ALA VAL SEQRES 12 A 177 GLU ASP MET ARG HIS LEU TYR THR PHE ARG VAL ASN PHE SEQRES 13 A 177 GLN GLU ARG VAL PHE PRO LEU PHE SER VAL CME SER THR SEQRES 14 A 177 GLY THR TYR LEU ARG ILE TRP PRO SEQRES 1 B 177 SER HIS MET LYS GLU GLU LYS VAL GLU LEU THR LEU ASP SEQRES 2 B 177 PRO ASP THR ALA ASN PRO ARG LEU ILE LEU SER LEU ASP SEQRES 3 B 177 LEU LYS GLY VAL ARG LEU GLY GLU ARG ALA GLN ASP LEU SEQRES 4 B 177 PRO ASN HIS PRO CME ARG PHE ASP THR ASN THR ARG VAL SEQRES 5 B 177 LEU ALA SER CYS GLY PHE SER SER GLY ARG HIS HIS TRP SEQRES 6 B 177 GLU VAL GLU VAL GLY SER LYS ASP GLY TRP ALA PHE GLY SEQRES 7 B 177 VAL ALA ARG GLU SER VAL ARG ARG LYS GLY LEU THR PRO SEQRES 8 B 177 PHE THR PRO GLU GLU GLY VAL TRP ALA LEU GLN LEU ASN SEQRES 9 B 177 GLY GLY GLN TYR TRP ALA VAL THR SER PRO GLU ARG SER SEQRES 10 B 177 PRO LEU SER CYS GLY HIS LEU SER ARG VAL ARG VAL ALA SEQRES 11 B 177 LEU ASP LEU GLU VAL GLY ALA VAL SER PHE TYR ALA VAL SEQRES 12 B 177 GLU ASP MET ARG HIS LEU TYR THR PHE ARG VAL ASN PHE SEQRES 13 B 177 GLN GLU ARG VAL PHE PRO LEU PHE SER VAL CME SER THR SEQRES 14 B 177 GLY THR TYR LEU ARG ILE TRP PRO MODRES 6UMB CME A 378 CYS MODIFIED RESIDUE MODRES 6UMB CME A 390 CYS MODIFIED RESIDUE MODRES 6UMB CME A 501 CYS MODIFIED RESIDUE MODRES 6UMB CME B 378 CYS MODIFIED RESIDUE MODRES 6UMB CME B 501 CYS MODIFIED RESIDUE HET CME A 378 10 HET CME A 390 17 HET CME A 501 10 HET CME B 378 10 HET CME B 501 10 HET MLI A 601 7 HET BME A 602 4 HET MLI B 601 7 HET BME B 602 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM MLI MALONATE ION HETNAM BME BETA-MERCAPTOETHANOL FORMUL 1 CME 5(C5 H11 N O3 S2) FORMUL 3 MLI 2(C3 H2 O4 2-) FORMUL 4 BME 2(C2 H6 O S) FORMUL 7 HOH *165(H2 O) HELIX 1 AA1 THR A 427 GLU A 430 5 4 HELIX 2 AA2 THR B 427 GLU B 430 5 4 SHEET 1 AA1 7 LEU A 355 LEU A 357 0 SHEET 2 AA1 7 GLY A 363 LEU A 366 -1 O ARG A 365 N ILE A 356 SHEET 3 AA1 7 LEU A 507 TRP A 510 -1 O LEU A 507 N VAL A 364 SHEET 4 AA1 7 ARG A 396 VAL A 403 -1 N GLU A 402 O ARG A 508 SHEET 5 AA1 7 ARG A 460 ASP A 466 -1 O LEU A 465 N HIS A 397 SHEET 6 AA1 7 ALA A 471 ALA A 476 -1 O SER A 473 N ALA A 464 SHEET 7 AA1 7 ARG A 481 ARG A 487 -1 O LEU A 483 N PHE A 474 SHEET 1 AA2 6 ARG A 385 LEU A 387 0 SHEET 2 AA2 6 VAL A 494 VAL A 500 -1 O PHE A 498 N VAL A 386 SHEET 3 AA2 6 TRP A 409 ARG A 415 -1 N ALA A 414 O PHE A 495 SHEET 4 AA2 6 VAL A 432 ASN A 438 -1 O TRP A 433 N VAL A 413 SHEET 5 AA2 6 GLN A 441 ALA A 444 -1 O TRP A 443 N GLN A 436 SHEET 6 AA2 6 SER A 451 PRO A 452 -1 O SER A 451 N ALA A 444 SHEET 1 AA3 7 LEU B 355 LEU B 357 0 SHEET 2 AA3 7 GLY B 363 LEU B 366 -1 O ARG B 365 N ILE B 356 SHEET 3 AA3 7 LEU B 507 TRP B 510 -1 O LEU B 507 N VAL B 364 SHEET 4 AA3 7 ARG B 396 VAL B 403 -1 N GLU B 402 O ARG B 508 SHEET 5 AA3 7 ARG B 460 ASP B 466 -1 O LEU B 465 N HIS B 397 SHEET 6 AA3 7 ALA B 471 ALA B 476 -1 O ALA B 471 N ASP B 466 SHEET 7 AA3 7 HIS B 482 ARG B 487 -1 O LEU B 483 N PHE B 474 SHEET 1 AA4 6 ARG B 385 LEU B 387 0 SHEET 2 AA4 6 VAL B 494 VAL B 500 -1 O PHE B 498 N VAL B 386 SHEET 3 AA4 6 TRP B 409 ARG B 415 -1 N ALA B 414 O PHE B 495 SHEET 4 AA4 6 VAL B 432 ASN B 438 -1 O TRP B 433 N VAL B 413 SHEET 5 AA4 6 GLN B 441 ALA B 444 -1 O TRP B 443 N GLN B 436 SHEET 6 AA4 6 SER B 451 LEU B 453 -1 O LEU B 453 N TYR B 442 LINK C PRO A 377 N CME A 378 1555 1555 1.35 LINK C CME A 378 N ARG A 379 1555 1555 1.34 LINK C SER A 389 N CME A 390 1555 1555 1.33 LINK C CME A 390 N GLY A 391 1555 1555 1.34 LINK C VAL A 500 N CME A 501 1555 1555 1.34 LINK C CME A 501 N SER A 502 1555 1555 1.34 LINK C PRO B 377 N CME B 378 1555 1555 1.33 LINK C CME B 378 N ARG B 379 1555 1555 1.33 LINK C VAL B 500 N CME B 501 1555 1555 1.33 LINK C CME B 501 N SER B 502 1555 1555 1.34 CISPEP 1 SER A 447 PRO A 448 0 3.10 CISPEP 2 TRP A 510 PRO A 511 0 -3.98 CISPEP 3 SER B 447 PRO B 448 0 18.38 CISPEP 4 TRP B 510 PRO B 511 0 11.92 SITE 1 AC1 8 ASN A 383 THR A 384 ARG A 385 PHE A 426 SITE 2 AC1 8 ARG A 487 SER A 499 CME A 501 HOH A 744 SITE 1 AC2 7 ARG A 415 TRP A 433 ASN A 489 PHE A 490 SITE 2 AC2 7 GLN A 491 GLU A 492 HOH A 742 SITE 1 AC3 8 ASN B 383 THR B 384 ARG B 385 PHE B 426 SITE 2 AC3 8 SER B 499 CME B 501 HOH B 701 HOH B 734 SITE 1 AC4 1 CME B 501 CRYST1 62.360 67.440 85.690 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016036 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014828 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011670 0.00000